古汉医药：预计2025年全年净亏损4500万元—5500万元

Group 1 - The company Gu Han Medicine has released an annual performance forecast, expecting a net profit attributable to shareholders of the listed company to be between -55 million and -45 million yuan for the year 2025 [1] - The expected net profit after deducting non-recurring gains and losses is projected to be between -65 million and -55 million yuan for the same period [1] - The main reasons for the expected loss include: (1) Impact from industry policies and rising procurement costs of raw materials leading to a slight decline in overall gross profit [1] (2) Impairment testing and provision for goodwill related to the acquisition of Guangdong Xiantong's equity due to changes in industry trends and market conditions [1] (3) Provision for credit impairment of receivables based on accounting standards and the company's actual operating conditions [1]